advertisement
PURPOSE: This study aims to determine if using pilocarpine postoperatively affects clinical outcomes after goniotomy. METHODS: Retrospective series comparing 532 Kahook Dual Blade goniotomy (KDB-G) procedures with (P+) or without (P-) pilocarpine use in the postoperative period. This study includes patients with both primary and secondary glaucoma ranging from mild to end-stage, undergoing KDB-G with or without phacoemulsification (phaco). The primary outcome measure was surgical success defined as intraocular pressure (IOP) < 21 mmHg in addition to either a reduction of >20% and/or the reduction of ≥1 topical glaucoma medications. Secondary outcomes were mean IOP, number of medications, and rate of hyphema and IOP spike at one week postoperatively. RESULTS: The success rate was significantly greater in Group P + at postoperative month 1 ( = .02), 3 ( = .01), 12 ( = .048), and 16 ( = .02). The differences in mean IOP ( = .084) and number of medications ( = .15) were not significantly different at one year. However, Group P + required significantly less medications than Group P - at nearly all time points (months 1, 3, 6, 20, and 24). There were no differences in rates of hyphema ( = .30) or postoperative week 1 IOP spikes ( = .66) between groups. CONCLUSION: The use of pilocarpine postoperatively may improve surgical success and may reduce the number of glaucoma medications needed after goniotomy.
Department of Ophthalmology, University of Colorado, Aurora, CO, USA.
Full article